P. Mulvenna

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

Aravinthan Varatharaj, Naomi Thomas, Mark Ellul et al. · The Lancet Psychiatry · 2020 · 1.3K citations · Full text

Medicine, Infectious Diseases, Neurology +13

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

P. Mulvenna, Matthew Nankivell, Rachael Barton et al. · The Lancet · 2016 · 727 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Interim Data from the Medical Research Council QUARTZ Trial: Does Whole Brain Radiotherapy Affect the Survival and Quality of Life of Patients with Brain Metastases from Non-small Cell Lung Cancer?

Ruth E. Langley, Richard Stephens, Matthew Nankivell et al. · Clinical Oncology · 2012 · 101 citations

Medicine, Oncology, Radiation Oncology +16

Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012

Matthias Preusser, Frank Winkler, Laurence Collette et al. · European Journal of Cancer · 2012 · 41 citations · Full text

Medicine, Oncology, Surgery +14

Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).

P. Mulvenna, Matthew Nankivell, Rachael Barton et al. · Journal of Clinical Oncology · 2015 · 29 citations

Medicine, Oncology, Radiation Oncology +17